Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 196 AL 210

Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease

Collins EC, Lu M, Beck R, Hendrix J, Hodsdon ME, Hansson O.

Alzheimers Dement. 2026 Aug;22(8):e71740. doi: 10.1002/alz.71740.

Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility

Hazan J, Salemme S, Liu KY, Howard R.

Neurology. 2026 Sep 8;107(5):e218403. doi: 10.1212/WNL.0000000000218403. Epub 2026 Aug 12.

Optimized plasma p-tau217 and p-tau217/Aβ42 cutoffs enhance detection of pre-clinical Alzheimer's disease across diverse participants

Piura YD, Aduen PA, Schecter L, Jain MK, Algeciras-Schimnich A, Figdore DJ, Bornhorst J, Petersen RC, Jr CRJ, Graff-Radford NR, Lachner C, Day GS.

Alzheimers Dement. 2026 Aug;22(8):e71763. doi: 10.1002/alz.71763.

Exosome-derived biomarkers as non-invasive tools in stroke, Parkinson's disease, and Alzheimer's disease

Talebi A, Nabili S, Alaei M, Koohsarian P, Doostmohammadi A, Dadashpour M.

Metab Brain Dis. 2026 Aug 20;41(1):189. doi: 10.1007/s11011-026-01947-0.

The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research

Gabel M, Goswami S, Bekena S, Solomon ED, Moulder KL, Morris JC, Mozersky J.

Alzheimers Dement. 2026 May;22(5):e71356. doi: 10.1002/alz.71356.

Effects of a 24-week resistance exercise program on Alzheimer's disease brain signatures in cognitively unimpaired older adults: a secondary analysis of the AGUEDA randomized controlled trial

Sanchez-Martinez J, Solis-Urra P, Fernandez-Gamez B, Fernández-Ortega J, Sánchez-Aranda L, Erickson KI, Ortega FB, Esteban-Cornejo I.

Age Ageing. 2026 Apr 4;55(4):afag086. doi: 10.1093/ageing/afag086.

Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0

Barthel H, Brendel M, Albert N, Boecker H, Bouter C, Brumberg J, Buchert R, La Fougère C, Gründer G, Hesse S, Kuwert T, Lange C, Langen KJ, Lohmann P, Meyer PT, Miederer I, Neumaier B, Rominger A, Schreckenberger M, Schulz JB, Yakushev I, Drzezga A.

Nuklearmedizin. 2026 Jun;65(3):223-235. doi: 10.1055/a-2784-7335. Epub 2026 May 21.

The TBI-AD/ADRD Caregiver Support Intervention (TACSI): Protocol of a Pilot Randomized Controlled Trial Evaluation of a Remote Intervention for Family Caregivers

Ostenso S, Birkeland RW, Albers E, Louwagie KW, Iwan A, Chesak SS, Gaugler JE.

JMIR Res Protoc. 2026 Mar 17;15:e81125. doi: 10.2196/81125.

Sporadic Alzheimer's disease with bipolar-like features: a case report and a brief review of the current research status

Kong L, Yang Y, Zhou W, Hu S.

J Zhejiang Univ Sci B. 2026 Apr 15;27(4):416-425. doi: 10.1631/jzus.B2500307.

The efficacy and safety of Yokukansan for concomitant behavioral and psychological symptoms of Alzheimer's disease: a randomized, double-blinded clinical trial

Yuan M, Gu C, Nguyen TTT, Xu L, Chen X, Sun J, Zhong L, Zheng Y, Zhang L, Lu Q, Yuan C, Xu H.

J Ethnopharmacol. 2026 Jul 15;366:121644. doi: 10.1016/j.jep.2026.121644. Epub 2026 Apr 7.

Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study

Povala G, Bellaver B, Lussier FZ, Amaral L, Bauer-Negrini G, Ferreira PCL, Rocha A, Ruppert E, Medeiros MS, Tissot C, Jagust WJ, Masdeu JC, Fortea J, Tudorascu DL, Soleimani-Meigooni DN, Lowe V, Oh H, Pascual B, Gordon BA, Rosa-Neto P, Baker S, Pascoal TA; HEAD Study.

Lancet. 2026 May 30;407(10544):2217-2226. doi: 10.1016/S0140-6736(26)00417-4.

Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer's disease: An assessor-blinded randomized controlled trial

Kim MG, Woo SH, Kim GW, Choi HK, Kim KK, Koo BS.

J Alzheimers Dis. 2026 May;111(1):397-409. doi: 10.1177/13872877261431692. Epub 2026 Mar 16.

A Mobile Self-Assessment and Referral Platform for Family Caregivers of Individuals With Alzheimer Disease and Related Dementias: Protocol for a Pilot Randomized Controlled Trial

Falzarano F, Greenfield A, Mason H, Bumbalova K, Rojas E, Bumbalov A.

JMIR Res Protoc. 2026 Apr 1;15:e90244. doi: 10.2196/90244.

Digital and Analogical Cognitive Stimulation in Older Adults with Alzheimer's Disease: A Multicenter Randomized Controlled Trial Study Protocol

Justo-Henriques SI, Padeiro M, Silva RCG, Macedo J, Borges-Machado F, São João RMV, Ribeiro O.

Acta Med Port. 2026 Apr 1;39(4):281-286. doi: 10.20344/amp.24360. Epub 2026 Apr 1.

Phase II clinical trial of KCHO-1 for Alzheimer's disease: study protocol for a multicenter, randomized, double-blind, multi-dose, placebo trial

Shin J, Jeong TS, Jung HS, Kim D, Kim CH, Yi S, Kang HW, Han D, Kim S.

Trials. 2026 Feb 26;27(1):266. doi: 10.1186/s13063-026-09572-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias